Ottawa, Canada, firm gains FDA approval to test potential COVID-19 drug

On: September 10, 2020

Following on promising mice-based research that indicated THC might provide effective protection from acute respiratory distress syndrome (ARDS), Ottawa, Canada-based Tetra Bio-Pharma has received FDA approval for Phase 1 testing of its synthetic cannabinoid drug, ARDS-003. ARDS is a severe lung injury that leads to significant morbidity and mortality, especially in older people, and the […]

Ottawa, Canada, firm gains FDA approval to test potential COVID-19 drug is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Previous Post: Canada’s cannabis concentrate market slowly comes to life, revealing producers’ strategies

Next Post: Study shows CBD may improve memory function

Comments are closed, but trackbacks and pingbacks are open.